Thank you for your interest in the seminar
“Enhancing anti-cancer immune response by targeting glycosylated PD-L1″.
Objectives:
1. Immunity and cancers.
2. Glycosylation of program death ligand-1 (PD-L1).
3. Anti-cancer therapies.
4. GeneTex’s featured products.
Time:
1 p.m.-2 p.m. 19th November (GMT)
To join the webinar, please register below:
